This inventor holds 1 USPTO granted patent. Top assignee: Gendaq Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Christophe Demaison
Introduction
Christophe Demaison is a notable inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in the modulation of HIV infection. His innovative approach has the potential to impact the treatment and management of this serious health issue.
Latest Patents
Demaison holds a patent for a method titled "Modulation of HIV infection." This patent discloses methods and compositions for modulating HIV infection by regulating the expression of one or more receptors. This groundbreaking work showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Christophe has demonstrated a strong dedication to research and innovation. His work at Gendaq Limited has allowed him to collaborate with other talented professionals in the field. His contributions have been recognized within the scientific community, and he continues to push the boundaries of what is possible in HIV research.
Collaborations
Demaison has worked alongside notable colleagues such as Michael Moore and Mark Isalan. These collaborations have enriched his research and expanded the impact of his work in the field of HIV modulation.
Conclusion
Christophe Demaison's innovative work in the modulation of HIV infection highlights his role as a leading inventor in the medical research community. His contributions are paving the way for new treatments and improved health outcomes for individuals affected by HIV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile